Analyst Consensus ?
ConsensusBuy31 ratings
Bullish1858.1%
Neutral1238.7%
Bearish13.2%
1 unmapped firm rating excluded from the percentages.
Regency Centers Corporation · REG · FY2025 Q3 · Calendar Q4 2025
Regency Centers sustains leasing growth while expanding development
The current analysis supports a constructive operating thesis: resilient leasing, rent growth, development activity and grocery-anchored demand remain the core growth drivers. The main counterweights are refinancing costs, credit-loss assumptions and the challenge of sustaining near-peak occupancy and rent spreads.
Reported After market closeNASDAQReal Estate
$13.08B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.15
Consensus $1.15
EPS surprise
0.0%
Reported versus consensus
Reported revenue
$387.0M
Consensus $388.6M
Revenue surprise
-0.4%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-3.1%
Event window
SPY move
+0.0%
Same window
Abnormal move
-3.1%
Stock minus SPY
Volume
1.4×
Versus trailing sessions
Subsequent drift
+2.8%
Up to 20 sessions
REGSPY benchmark
Ask FN2 about REG FY2025 Q3
Transcript, numbers and history already loaded
Why did REG fall 3.1% after beating EPS estimates in FY2025 Q3?What changed in REG's guidance and outlook in FY2025 Q3?Give me the bull and bear case for REG after FY2025 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior quarter, the current analysis emphasizes continued acquisition execution, a larger development pipeline and a planned 2026 development pace, while retaining a raised outlook and dividend-growth focus. Refinancing and credit-loss assumptions remain the principal areas to monitor.
Guidance delta
Management raised the full-year earnings outlook and dividend in the current analysis, following a raised outlook in the prior quarter.
Key takeaways
- Same-property NOI grew more than 5% year over year, supported by 4.7% base-rent growth.
- Management highlighted continued acquisitions, including a $350 million five-property South Orange County portfolio.
- The development pipeline exceeds $650 million, with $300 million of new starts targeted in 2025.
- Tenant health remains strong, while refinancing and credit losses are the main watch items.
Management priorities
- Accelerate ground-up development, targeting $300 million of starts in 2025 and a similar pace in 2026.
- Pursue opportunistic acquisitions focused on high-quality grocery-anchored assets.
- Recycle capital through sales of non-strategic assets and reinvestment in higher-IRR projects.
- Maintain dividend growth and use the A-rated balance sheet to support financing.
Follow REG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$71.6Current
$60Low
$80.53Average
$92High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 4, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Overweight | Overweight | Maintain | Sep 28, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Sep 24, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Sep 24, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Sep 21, 2026 |
| Scotiabank | Sector Perform | Sector Perform | Maintain | Sep 17, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 19, 2026 |
| Ladenburg Thalmann | Neutral | Neutral | Maintain | Jul 31, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 9, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 5, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 21, 2026 |
| Truist Securities | Buy | Buy | Maintain | Mar 2, 2026 |
| Keybanc | Overweight | Downgrade | Dec 4, 2025 | |
| Baird | Outperform | Outperform | Maintain | Jul 30, 2025 |
| BTIG | Buy | Buy | Maintain | Nov 27, 2024 |
| Deutsche Bank | Hold | Buy | Downgrade | Sep 26, 2024 |
| Compass Point | Buy | Buy | Maintain | Sep 10, 2024 |
| Raymond James | Outperform | Outperform | Maintain | Aug 16, 2024 |
| Jefferies | Buy | Buy | Maintain | Mar 7, 2024 |
| Argus Research | Buy | Hold | Upgrade | Sep 20, 2023 |
| B of A Securities | Buy | Buy | Maintain | Aug 22, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Jun 23, 2022 |
| BMO Capital | Outperform | Market Perform | Upgrade | Dec 1, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jul 21, 2020 |
| RBC Capital | Outperform | Top Pick | Downgrade | Dec 14, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| BTIG Research | Buy | Neutral | Upgrade | Jan 29, 2018 |
| Boenning & Scattergood | Neutral | Underperform | Upgrade | Oct 3, 2017 |
| Roth Capital | Buy | Buy | Maintain | Apr 1, 2016 |
| Bank of America | Buy | Neutral | Upgrade | Dec 4, 2014 |
| ISI Group | Neutral | Buy | Downgrade | Dec 17, 2013 |
| Janney Capital | Neutral | Neutral | Maintain | Sep 10, 2013 |
| Goldman Sachs | Sell | Sell | Maintain | May 9, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $71.6. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Truist Financial | Analyst unavailable | $84 | $71.8 | +17.3% | Oct 1, 2026 |
| Barclays | Richard Hightower | $85 | $73.23 | +18.7% | Sep 28, 2026 |
| Goldman Sachs | Analyst unavailable | $83 | $72.73 | +15.9% | Sep 24, 2026 |
| Griffin | Michael Griffin | $81 | $73.04 | +13.1% | Sep 21, 2026 |
| Scotiabank | Nicholas Yulico | $81 | $73.04 | +13.1% | Sep 17, 2026 |
| Barclays | Analyst unavailable | $92 | $76.71 | +28.5% | Aug 17, 2026 |
| Argus Research | Analyst unavailable | $85 | $76.15 | +18.7% | Aug 10, 2026 |
| Evercore ISI | Analyst unavailable | $83 | $80.06 | +15.9% | Jul 30, 2026 |
| Wells Fargo | Jamie Feldman | $90 | $82.22 | +25.7% | Jul 23, 2026 |
| UBS | Analyst unavailable | $85 | $79.72 | +18.7% | Jul 9, 2026 |
| Evercore ISI | Steve Sakwa | $81 | $80.87 | +13.1% | Jul 7, 2026 |
| Raymond James | Analyst unavailable | $88 | $81.68 | +22.9% | Jun 29, 2026 |
| BTIG | Analyst unavailable | $85 | $80.69 | +18.7% | Jun 12, 2026 |
| Deutsche Bank | Analyst unavailable | $85 | $78.52 | +18.7% | May 29, 2026 |
| Wells Fargo | Analyst unavailable | $88 | $78.84 | +22.9% | May 26, 2026 |
| UBS | Analyst unavailable | $81 | $77.33 | +13.1% | May 18, 2026 |
| Barclays | Richard Hightower | $90 | $77.72 | +25.7% | May 12, 2026 |
| Evercore ISI | Analyst unavailable | $80 | $77.59 | +11.7% | May 1, 2026 |
| Robert W. Baird | Analyst unavailable | $84 | $76.81 | +17.3% | Feb 10, 2026 |
| Deutsche Bank | Omotayo Okusanya | $83 | $71.47 | +15.9% | Jan 20, 2026 |
| UBS | Analyst unavailable | $76 | $69.52 | +6.1% | Jan 14, 2026 |
| Mizuho Securities | Analyst unavailable | $74 | $70.62 | +3.4% | Jan 9, 2026 |
| UBS | Analyst unavailable | $74 | $70.62 | +3.4% | Jan 9, 2026 |
| UBS | Michael Goldsmith | $75 | $69.99 | +4.7% | Jan 8, 2026 |
| Morgan Stanley | Ronald Kamdem | $85 | $68.09 | +18.7% | Jan 5, 2026 |
| Jefferies | Analyst unavailable | $79 | $68.24 | +10.3% | Dec 15, 2025 |
| Wells Fargo | Analyst unavailable | $82 | $72.21 | +14.5% | Oct 21, 2025 |
| Barclays | Analyst unavailable | $83 | $71.68 | +15.9% | Oct 6, 2025 |
| Scotiabank | Nicholas Yulico | $76 | $71.58 | +6.1% | Aug 28, 2025 |
| Truist Financial | Ki Bin Kim | $81 | $71.02 | +13.1% | Aug 15, 2025 |
| Wells Fargo | Dori Kesten | $79 | $72.83 | +10.3% | Mar 26, 2025 |
| Scotiabank | Analyst unavailable | $80 | $76.7 | +11.7% | Feb 28, 2025 |
| KeyBanc | Todd Thomas | $80 | $72.28 | +11.7% | Nov 4, 2024 |
| Evercore ISI | Steve Sakwa | $77 | $71.75 | +7.5% | Oct 29, 2024 |
| Deutsche Bank | Derek Johnston | $75 | $71.85 | +4.7% | Sep 26, 2024 |
| Evercore ISI | Samir Khanal | $75 | $74.68 | +4.7% | Sep 16, 2024 |
| Truist Financial | Ki Bin Kim | $78 | $70.01 | +8.9% | Aug 15, 2024 |
| Truist Financial | Ki Bin Kim | $70 | $60.61 | -2.2% | May 20, 2024 |
| Scotiabank | Greg McGinnis | $65 | $60.42 | -9.2% | May 16, 2024 |
| Mizuho Securities | Haendel Juste | $60 | $57.29 | -16.2% | Apr 18, 2024 |
| Wells Fargo | Dori Kesten | $70 | $62.9 | -2.2% | Mar 5, 2024 |
| Evercore ISI | Steve Sakwa | $71 | $62.97 | -0.8% | Jan 22, 2024 |
| Morgan Stanley | Ronald Kamdem | $75 | $65.54 | +4.7% | Dec 21, 2023 |
| Barclays | Ross Smotrich | $71 | $67.02 | -0.8% | Dec 18, 2023 |
| BTIG | Michael Gorman | $77 | $71.15 | +7.5% | Dec 15, 2021 |
| Evercore ISI | Samir Khanal | $82 | $71.81 | +14.5% | Dec 6, 2021 |
| Barclays | Anthony Powell | $78 | $73.35 | +8.9% | Nov 17, 2021 |
Track every rating change on REG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationRegency Centers is recognized as a leading national entity specializing in the ownership, management, and development of retail complexes. These properties are strategically located in prosperous and densely populated market regions. The company's portfolio showcases a collection of thriving sites, expertly curated with high-performing supermarkets, popular eateries, essential service businesses, and premier retailers, all deeply integrated with their local neighborhoods, communities, and clientele. Operating as a comprehensive real estate firm, Regency Centers is a qualified Real Estate Investment Trust (REIT), characterized by its self-administered and self-managed structure, and is a respected constituent of the S&P 500 Index.
Historical context
All REG earningsLatest beats and misses
Who reports nextBeat on EPS
- ACNFY2026 Q4 · October 1, 2026+3.5% EPS+15.8% move
- MKCFY2026 Q3 · October 1, 2026+13.9% EPS-4.9% move
- NKEFY2027 Q1 · October 1, 2026+10.0% EPS-0.7% move
- CAGFY2027 Q1 · September 30, 2026+44.4% EPS-4.9% move
- FDSFY2026 Q4 · September 30, 2026+3.9% EPS+3.8% move
- JBLFY2026 Q4 · September 30, 2026+8.1% EPS-10.0% move
Get the REG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-10-03T22:40:40.488547+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-03T22:40:40.485788+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-03. For educational purposes only; not investment advice.